Patent FR1120748A successfully refreshed from Google Patents.
Patent US3914408A successfully refreshed from Google Patents.
← Back to Patent Explorer
US3914408A Expired / Lapsed US ⏱️ 0.0 years remaining

Vaccine for neonatal calf diarrhea

Assignee: University of Nebraska–Lincoln
•
Filing: 1974-11-29
•
Granted: 1975-10-21
•
Expires: 1994-11-29
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A vaccine is prepared by passaging a coronavirus-like agent in tissue culture or by inactivating the viral agent. The vaccine is useful for immunizing bovine animals against calf diarrhea.

Inventors

  • 👤 Charles A Mebus

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-07 11:07
CPC Classifications
A; A61; A61K; A61K39/00; A61K39/12; A61K39/215; A61K2039/51; A61K2039/525; A61K2039/5252; A61K2039/5254; A61K2039/54; A61K2039/541; A61K2039/542; A61K2039/55; A61K2039/552; A61K2039/555; A61K2039/55505; A61K2039/70; C; C12; C12N; C12N2720/00; C12N2720/00011; C12N2720/12011; C12N2720/12311; C12N2720/12334; C12N2770/00; C12N2770/00011; C12N2770/20011; C12N2770/20034; Y; Y10; Y10S; Y10S424/00; Y10S424/813

Claims Analysis

Total Claims: 8
Claim 1
Independent Claim 36 words
A COMBINATION PARENTAL CALF DIARRHEA VACCINE COMPRISING AN IMMUNIZING-EFFECTIVE AMOUNT OF AN INACTIVATED BOVINE CELL CULTURE PROPAGATED CORONAVIRUS-LIKE CALF DIARRHEA VIRUS AND AN IMMUNIZING-EFFECTIVE AMOUNT OF AN INACTIVATED BOVINE CELL CULTURE PROPAGATED REOVIRUS-LIKE CALF DIARRHEA VIRUS.
Claim 2
Dependent Claim 36 words
A COMBINATION PARENTAL CALF DIARRHEA VACCINE COMPRISING AN IMMUNIZING-EFFECTIVE AMOUNT OF AN INACTIVATED BOVINE CELL CULTURE PROPAGATED CORONAVIRUS-LIKE CALF DIARRHEA VIRUS AND AN IMMUNIZING-EFFECTIVE AMOUNT OF AN INACTIVATED BOVINE CELL CULTURE PROPAGATED REOVIRUS-LIKE CALF DIARRHEA VIRUS.
Claim 3
Dependent Claim 76 words
A method for immunizing a newborn calf against neonatal calf diarrhea caused by a coronavirus-like or reovirus-like calf diarrhea virus comprising parenterally administering at least 1 ml. of the combination vaccine claimed in claim 1 to either an adult pregnant cow 30 to 90 days prior to the birth of said newborn calf and causing the said calf to ingest the colostrum or milk containing protective antibodies or to the said newborn calf soon after birth.
Claim 4
Dependent Claim 17 words
A vaccine according to claim 1, in which the amounts of the two viruses are approximately equal.
Claim 5
Dependent Claim 12 words
A vaccine according to claim 1, in which an adjuvant is present.
Claim 6
Dependent Claim 20 words
A vaccine according to claim 1, in which the adjuvant is aluminum hydroxide gel, potassium alum, alginate, or mineral oil.
Claim 7
Dependent Claim 15 words
A vaccine according to claim 1, in which both viruses have been inactivated with formalin.
Claim 8
Dependent Claim 37 words
A vaccine according to claim 1, in which the coronavirus-like virus has been attenuated by about 27 passages in bovine kidney cells and the reovirus-like virus has been attenuated by about 201 passages in bovine kidney cells.

References Cited (Backward Citations)

US3293129A Cited
US3839556A Cited
US3838004A Cited
US3869547A Cited
US3873422A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1978-10-20 1979-04-21 1979-10-21 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1982-10-20 1983-04-21 1983-10-21 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1986-10-20 1987-04-21 1987-10-21 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag